Minimally-invasive treatment for ovarian cancer using light therapy
Author Information
Author(s): Hornung R, Fehr M K, Monti-Frayne J, Tromberg B J, Berns M W, Tadir Y
Primary Institution: Beckman Laser Institute and Medical Clinic, University of California Irvine
Hypothesis
Can interstitial photodynamic therapy using PEG-m-THPC effectively reduce unrespectable pelvic ovarian cancer in rats?
Conclusion
PEG-m-THPC mediated photodynamic therapy can effectively and selectively reduce pelvic cancer bulk with minimal damage to normal organs.
Supporting Evidence
- The study involved 30 rats to assess tumor selectivity and necrosis.
- Survival of treated rats was significantly longer than untreated controls.
- Significant necrosis was achieved with specific doses of PEG-m-THPC and laser light.
Takeaway
This study tested a new light therapy to shrink ovarian cancer in rats, and it worked well without hurting other organs.
Methodology
Rats were treated with different doses of PEG-m-THPC and laser light to measure tumor necrosis and survival.
Participant Demographics
Immunocompetent rats, specifically NuTu-19 tumor-bearing rats.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website